- $2.56m
- -$13.12m
- $42.30m
- 64
- 100
- 1
- 55
Annual balance sheet for C3is, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | 20-F | 20-F |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | — | 9.06 | 12.6 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.822 | 10.4 | 2.82 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 1.02 | 20.3 | 16.3 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 38.8 | 75.2 | 84.1 |
Total Assets | 39.9 | 95.5 | 100 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 0.965 | 39.9 | 18.7 |
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 0.965 | 39.9 | 29.1 |
Non Redeemable Preferred Stock | |||
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 38.9 | 55.5 | 71.4 |
Total Liabilities & Shareholders' Equity | 39.9 | 95.5 | 100 |
Total Common Shares Outstanding |